Literature DB >> 30192325

Extended Venous Thromboembolism Prophylaxis After Elective Surgery for IBD Patients: Nomogram-Based Risk Assessment and Prediction from Nationwide Cohort.

Cigdem Benlice1, Stefan D Holubar, Emre Gorgun, Luca Stocchi, Jeremy M Lipman, Matthew F Kalady, Bradley J Champagne, Scott R Steele.   

Abstract

BACKGROUND: Identification of risk factors for postoperative venous thromboembolism is an important step to reduce the morbidity associated with this potentially preventable complication after elective surgery for patients with IBD.
OBJECTIVE: This study aimed to determine the risk factors for 30-day venous thromboembolism after abdominal surgery for patients with venous thromboembolism, identify potential indications for extended thromboprophylaxis, and develop a nomogram for prediction of risk.
DESIGN: This is a retrospective cohort study from a prospectively collected database.
SETTING: The American College of Surgeons National Surgical Quality Improvement Program Participant User File from 2005 to 2016 was used for data analysis. PATIENTS: All patients with IBD undergoing elective abdominopelvic bowel surgery were included. MAIN OUTCOME MEASURES: The primary outcomes were the incidence of in-hospital and postdischarge venous thromboembolism within 30 days of the index abdominopelvic surgery.
RESULTS: A total of 24,182 patients met the inclusion criteria. Thirty-day total and postdischarge rates of venous thromboembolism were 2.5% (n = 614) and 1% (n =252). Forty-one percent (252/614) of venous thromboembolism events occurred after hospital discharge. Univariate analysis assessed 37 variables for association with study outcomes. On multivariate logistic regression analysis, older age, steroid use, bleeding disorders, open surgery, hypertension, longer operative time, and preoperative hospitalization were associated with venous thromboembolism before discharge and also postoperative transfusion, steroid use, pelvic and enterocutaneous fistula surgery, and longer operative time were associated with venous thromboembolism after discharge. A nomogram was constructed for each outcome, translating multivariate model parameter estimates into a visual scoring system where the estimated probability of venous thromboembolism can be calculated. LIMITATIONS: This study was limited by its retrospective nature and the limitations inherent to a database.
CONCLUSION: Given the higher risk of venous thromboembolism in patients with IBD after elective abdominopelvic surgery compared with other indications, an accurate prediction of venous thromboembolism before and after discharge using the proposed nomogram can facilitate decision making for individualized extended thromboprophylaxis in the preoperative setting as a screening tool. See Video Abstract at http://links.lww.com/DCR/A711.

Entities:  

Mesh:

Year:  2018        PMID: 30192325     DOI: 10.1097/DCR.0000000000001189

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  8 in total

1.  Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases.

Authors:  Adam S Faye; Timothy Wen; Ashwin N Ananthakrishnan; Simon Lichtiger; Gilaad G Kaplan; Alexander M Friedman; Garrett Lawlor; Jason D Wright; Frank J Attenello; William J Mack; Benjamin Lebwohl
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-20       Impact factor: 11.382

2.  Do Cost Limitations of Extended Prophylaxis After Surgery Apply to Ulcerative Colitis Patients?

Authors:  Ira L Leeds; Joseph K Canner; Sandra R DiBrito; Bashar Safar
Journal:  Dis Colon Rectum       Date:  2022-05-01       Impact factor: 4.585

3.  International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.

Authors:  Pablo A Olivera; Stephane Zuily; Paulo G Kotze; Veronique Regnault; Sameer Al Awadhi; Peter Bossuyt; Richard B Gearry; Subrata Ghosh; Taku Kobayashi; Patrick Lacolley; Edouard Louis; Fernando Magro; Siew C Ng; Alfredo Papa; Tim Raine; Fabio V Teixeira; David T Rubin; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-27       Impact factor: 46.802

4.  Cost-Benefit Limitations of Extended, Outpatient Venous Thromboembolism Prophylaxis Following Surgery for Crohn's Disease.

Authors:  Ira L Leeds; Sandra R DiBrito; Joseph K Canner; Elliott R Haut; Bashar Safar
Journal:  Dis Colon Rectum       Date:  2019-11       Impact factor: 4.585

Review 5.  Venous thromboembolism in inflammatory bowel disease.

Authors:  Kimberly Cheng; Adam S Faye
Journal:  World J Gastroenterol       Date:  2020-03-28       Impact factor: 5.742

6.  Essential updates 2018/2019: Colorectal (benign): Recent updates (2018-2019) in the surgical treatment of benign colorectal diseases.

Authors:  Takayuki Ogino; Tsunekazu Mizushima; Chu Matsuda; Masaki Mori; Yuichiro Doki
Journal:  Ann Gastroenterol Surg       Date:  2019-12-16

7.  The Duration and Magnitude of Postdischarge Venous Thromboembolism Following Colectomy.

Authors:  Christopher A Lewis-Lloyd; David J Humes; Joe West; Oliver Peacock; Colin J Crooks
Journal:  Ann Surg       Date:  2022-07-19       Impact factor: 13.787

8.  A postdischarge venous thromboembolism risk calculator for inflammatory bowel disease surgery.

Authors:  Cary Jo R Schlick; Tarik K Yuce; Anthony D Yang; Michael F McGee; David J Bentrem; Karl Y Bilimoria; Ryan P Merkow
Journal:  Surgery       Date:  2020-10-17       Impact factor: 3.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.